Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
1
0
0
Vyant Bio, Inc.
Share · US92942V2088 · VYNT (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Vyant Bio, Inc.
Analyst Grade Summary
No Price
Company Profile for Vyant Bio, Inc. Share
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.
Company Data
Name Vyant Bio, Inc.
Company Vyant Bio, Inc.
Symbol VYNT
Website
https://www.vyantbio.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US92942V2088
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Andrew D.C. LaFrence CPA
Country United States of America
Currency USD
Employees 0,0 T
Address 2 Executive Campus, 08002 Cherry Hill
IPO Date 2021-04-01
Stock Splits
| Date | Split |
|---|---|
| 02.11.2022 | 1:5 |
| 25.10.2019 | 1:30 |
ID Changes
| Date | From | To |
|---|---|---|
| 31.03.2021 | CGIX | VYNT |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | VYNT |
More Shares
Investors who hold Vyant Bio, Inc. also have the following shares in their portfolio:
